U.S. Stock News

NasdaqGM:NUAI
NasdaqGM:NUAIOil and Gas

New Era Energy & Digital (NUAI) Is Down 8.0% After PJM Opens Tariff Review On Data-Center Loads

Earlier this month, regulators opened a Section 206 proceeding into PJM’s tariff rules for integrating large data-center loads, directly affecting New Era Energy & Digital’s data center and energy development plans in the region. By targeting how large, flexible and co-located loads pay for and access transmission upgrades, the review could materially influence New Era’s economics, grid access and long-term planning assumptions. We’ll now examine how PJM’s tariff review around integrating...
NYSE:KRP
NYSE:KRPOil and Gas

Kimbell Royalty Partners (KRP) Stock Could Be Pricey After $215.4m Acquisition

Kimbell Royalty Partners has delivered a 121.7% return over the past 5 years, yet its current valuation checks point to a stock that screens as overvalued on market multiples and only mixed on the broader metrics. That creates a clear tension for investors trying to weigh strong historical returns against what the current price implies. A 121.7% return over 5 years highlights that long term holders have already seen substantial gains, so the easy part of the rerating may be behind the...
NasdaqGS:MSFT
NasdaqGS:MSFTSoftware

Is Microsoft (MSFT) Below Fair Value After Heavy AI Spending?

Microsoft stock is coming off a weak year, with the share price down 22.2% over the past 12 months, yet the current checks suggest the market may be pricing it below what its fundamentals and cash flows imply, as both the Discounted Cash Flow (DCF) intrinsic value estimate and earnings multiples point to undervaluation. Over the past 5 years Microsoft has returned 41.7%, which shows that even with the recent pullback, long-term holders have still seen a solid gain. Heavy investment in AI...
NYSE:SRE
NYSE:SREIntegrated Utilities

Sempra (SRE) Stock Looks Above Fair Value After Its 65% Run

Sempra’s share price has climbed 65.1% over the past five years. With the stock recently closing at US$92.25 and broader checks flagging it as expensive, investors are weighing strong past returns against signals that it may no longer be a clear bargain. A 65.1% gain over five years highlights that Sempra has already delivered solid long term returns, which can raise the bar for what counts as attractively priced today. Progress at Sempra Infrastructure, including the first LNG cargo from...
NasdaqGS:GOOGL
NasdaqGS:GOOGLInteractive Media and Services

The Bull Case For Alphabet (GOOGL) Could Change Following EU AI Rules And Gemini Delay - Learn Why

In recent days, Alphabet has postponed the launch of its flagship Gemini 3.5 Pro AI model and faced a European Commission order requiring Google to open key Android features and anonymized Search data to rival AI developers under the Digital Markets Act from 2027. These twin pressures, execution setbacks in core AI products and tougher EU interoperability rules, raise fresh questions about Alphabet’s competitive moat in high‑value cloud, search, and mobile ecosystems. We’ll now examine how...
NYSE:TFC
NYSE:TFCBanks

Truist Financial (TFC) Stock Faces Flat Net Interest Margin Challenging Cost‑Saving Narratives

Truist Financial (TFC) has put fresh numbers on the table for Q2 2026, reporting total revenue of US$4.9 billion and basic EPS of US$1.24, with trailing twelve month EPS at US$4.41 and net income of US$5.5 billion. These figures give investors a clear view of current earnings power. Over recent quarters, the company has reported revenue moving from US$4.4 billion in Q1 2025 to US$4.9 billion in Q2 2026, while quarterly EPS has ranged from US$0.88 to US$1.24. This release therefore represents...
NYSE:PEN
NYSE:PENMedical Equipment

Penumbra (PEN) Starts The FORWARD Study, Is The Stock Already Expensive?

FORWARD stroke study puts Penumbra (PEN) thrombectomy platform in focus Penumbra (PEN) has kicked off the FORWARD study, an international, real world trial tracking safety and efficacy of its RED reperfusion catheter portfolio, including the newly cleared THUNDERBOLT thrombectomy platform. See our latest analysis for Penumbra. Penumbra’s US$318.32 share price has been relatively steady in recent weeks, with modest short term moves. The 1 year total shareholder return of 38.17% points to...
NasdaqGS:MU
NasdaqGS:MUSemiconductor

Micron Technology (MU) Following New Auto Supply Deals Is The Pullback A Value Chance

Micron Technology (MU) has just completed a set of long term Strategic Customer Agreements with major automotive suppliers, including Qualcomm, Visteon, HARMAN, JOYNEXT, DENSO, Astemo and Hyundai Mobis, focusing on consistent memory and storage supply. See our latest analysis for Micron Technology. Despite the recent announcement of new automotive supply agreements, Micron Technology’s recent pullback reflects broader profit taking in AI chip stocks. The 7 day share price return is 13.31%...
NasdaqGS:ZS
NasdaqGS:ZSSoftware

Has Zscaler (ZS) Fallen Below Fair Value After Its 48% Drop?

Zscaler stock has fallen 48.1% over the past year, yet on Simple Wall St’s checks it now screens as having meaningful upside to its intrinsic value based on a Discounted Cash Flow (DCF) estimate. That sets up a clear tension for investors, with a weak recent share price record on one side and a DCF view of the stock as materially undervalued on the other. Over the last year, Zscaler shares declined 48.1%, which means the current valuation is being assessed against a materially lower starting...
NYSE:J
NYSE:JProfessional Services

Is New Global Infrastructure Wins Altering The Investment Case For Jacobs Solutions (J)?

In recent weeks, TransnetBW, National Highways and the U.S. Naval Facilities Engineering Systems Command have each selected Jacobs Solutions for new framework and design contracts spanning power grid expansion in Germany, highway asset renewal in the U.K., and military facility planning in the U.S. These wins highlight Jacobs’ ability to act as an end-to-end partner on complex, long-duration infrastructure and energy projects across multiple geographies and sectors. We’ll now examine how...
NasdaqGM:EYPT
NasdaqGM:EYPTPharmaceuticals

Is EyePoint (EYPT) Recasting Its R&D Strategy With Dr. Hassan’s Appointment at the Helm?

EyePoint Pharmaceuticals has appointed Tarek S. Hassan, M.D., a globally recognized retina specialist with more than 35 years of experience, as Senior Vice President and Chief Strategic Science Officer, reporting directly to President and CEO Jay S. Duker and joining the executive leadership team. By bringing in a retina expert who has led over 180 multicenter trials and helped shape major global retinal organizations, EyePoint is explicitly tying scientific leadership to the development and...
NasdaqGS:VNOM
NasdaqGS:VNOMOil and Gas

Viper Energy (VNOM) Stock Looks Below Fair Value But Rich On Sales

Viper Energy has delivered a 21.1% return over the past year, yet its current valuation checks and recent acquisition of Riverbend Oil and Gas IX leave investors weighing whether the stock still offers attractive value at around US$44.38 a share. A 21.1% one year return suggests Viper Energy has rewarded shareholders recently, which raises the bar for any further upside from here. The completed US$337 million cash and stock acquisition of Riverbend Oil and Gas IX can support future cash flow...
NYSE:ARI
NYSE:ARIMortgage REITs

Apollo Commercial Real Estate Finance (ARI) Stock Loses Over A Dozen Russell Index Spots

Apollo Commercial Real Estate Finance (NYSE:ARI) was removed from over a dozen major Russell indices in a single day. The cuts followed its recent removal from key S&P indices. The changes occur while ARI is in an ongoing liquidation process. Apollo Commercial Real Estate Finance is a commercial mortgage real estate investment trust, so index inclusion has been an important channel for passive capital and trading volume. Being dropped from a broad set of Russell indices after earlier S&P...
NYSE:CMS
NYSE:CMSIntegrated Utilities

CMS Energy (CMS) Sees Data Center Demand Narrative Grow, Is It Still 8% Undervalued?

CMS Energy (CMS) is back on investors’ radar after recent trading left the stock roughly flat over the past month but lower over the past 3 months, inviting closer attention to its fundamentals. See our latest analysis for CMS Energy. At around $73.65, CMS Energy’s recent share price softness, including a 1-day decline of about 1% and a 7-day drop of roughly 2%, contrasts with a positive year to date share price return of 4.6% and multi year total shareholder returns between 5.5% and 38.4%...
NYSE:PCOR
NYSE:PCORSoftware

Is Procore Technologies (PCOR) Undervalued On Slowing ARR Growth And Ongoing Losses?

Recent commentary on Procore Technologies (PCOR) has focused on slowing annual recurring revenue growth and continued operating losses, which have contributed to weaker sentiment around the stock and questions about its cost base. See our latest analysis for Procore Technologies. Despite the recent concerns, Procore Technologies’ share price has shown a short-term rebound, with a 1-month share price return of 14.90% and a 7-day share price return of 6.05%. However, momentum has eased over a...
NasdaqGS:HIMX
NasdaqGS:HIMXSemiconductor

Himax Technologies (HIMX) Looks Undervalued On Paper, Is The Recent Pullback A Buying Opportunity?

Himax Technologies (HIMX) has drawn investor attention after a recent stretch of mixed share performance, with the stock down about 29% over the past month but up roughly 16% in the past 3 months. See our latest analysis for Himax Technologies. At a share price of $12.80, Himax Technologies has seen short term momentum fade with the 7 day share price return down 15.96% and the 30 day share price return down 29.32%. This comes even as the year to date share price return of 50.06% and 3 year...
NYSEAM:CMCL
NYSEAM:CMCLMetals and Mining

Is Caledonia Mining (NYSEAM:CMCL) Still A Bargain at This Price?

Caledonia Mining stock has given shareholders a 76.5% return over the past 5 years, yet its current share price of US$16.98 still screens as cheap when lined up against an intrinsic value estimate from a Discounted Cash Flow (DCF) model and traditional market multiples. Over 5 years, a 76.5% total return suggests Caledonia Mining has already rewarded patient investors, so the key issue now is whether the current price still offers a margin between value and expectations. Future cash flow...
NYSE:DRI
NYSE:DRIHospitality

Darden Restaurants (DRI) Revives Pasta Pass As Value Narrative Points To Upside

Darden Restaurants (DRI) is back in focus after Olive Garden revived its never ending pasta promotion and Pasta Pass, a value driven offer aimed at drawing budget conscious diners and supporting traffic. See our latest analysis for Darden Restaurants. The pasta promotion comes as Darden Restaurants’ share price has eased in the short term, with a 1-month share price return of 6.99% and a 7-day share price return of 2.80% both declining. In contrast, the 3-year total shareholder return of...
NYSE:ABBV
NYSE:ABBVBiotechs

How AbbVie’s New Rapid-Onset Boey Toxin Could Reshape Aesthetics Demand for AbbVie (ABBV) Investors

Earlier this month, Allergan Aesthetics, an AbbVie company, received European Commission approval for Boey (trenibotulinumtoxinE), the first rapid-onset, short-duration botulinum neurotoxin serotype E for temporarily improving moderate to severe glabellar lines across all 30 European Economic Area countries. By offering quicker visible results and a shorter treatment effect window than traditional neurotoxins, Boey introduces a differentiated option that could broaden AbbVie’s appeal to...
NYSE:STE
NYSE:STEMedical Equipment

Does STERIS' (STE) EPS Beat Streak Signal Durable Earnings Quality Or Just Managed Expectations?

Steris recently entered the spotlight as investors reacted to expectations around its now-past fiscal first-quarter 2027 earnings release, with analysts having projected a 7.7% increase in profit per share versus the prior year and pointing to a solid record of meeting or beating estimates. What stands out is how this anticipated profit improvement, combined with Steris’s track record in recent quarters, appears to be shaping confidence in the company’s ability to sustain its earnings...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

The Bull Case For Arcutis Biotherapeutics (ARQT) Could Change Following FDA Acceptance Of Infant ZORYVE sNDA

Arcutis Biotherapeutics recently announced that the FDA accepted its supplemental New Drug Application for ZORYVE (roflumilast) cream 0.05% to extend its approved use in mild to moderate atopic dermatitis to infants aged 3 to 24 months, supported by positive Phase 1 and Phase 2 infant studies. This move highlights how Arcutis is working to broaden ZORYVE’s reach into younger pediatric populations, deepening its presence in non-steroidal dermatology treatments across multiple age groups and...
NYSE:MCK
NYSE:MCKHealthcare

McKesson (MCK) Could Be 11% Undervalued Following Upbeat Earnings Expectations

McKesson (MCK) is back in focus as investors react to upbeat analyst sentiment ahead of its second quarter earnings, with forecasts calling for strong profit growth and closer scrutiny of the company’s guidance. See our latest analysis for McKesson. At a share price of $841.39, McKesson has seen a 12.09% 1 month share price return and a 19.02% 1 year total shareholder return, indicating that recent momentum aligns with longer term compounding. If the setup around McKesson has you thinking...
NasdaqGS:WTFC
NasdaqGS:WTFCBanks

Did Wintrust’s (WTFC) Northern Trust Guardianship Deal and Q2 Earnings Beat Just Shift Its Investment Narrative?

Wintrust Financial Corporation recently agreed to acquire Northern Trust’s guardianship services operations and is expected to report higher Q2 earnings than a year earlier. This combination of anticipated earnings strength and a targeted expansion into specialized fiduciary services could reshape how investors view Wintrust’s long-term business mix. Next, we will examine how the guardianship services acquisition influences Wintrust’s investment narrative and broader growth prospects for...
NasdaqGS:PANW
NasdaqGS:PANWSoftware

Palo Alto Networks (PANW) Could Be 129% Above Fair Value Following Capital One Upgrade

Why a recent upgrade is putting Palo Alto Networks in focus Capital One’s upgrade of Palo Alto Networks (PANW), tied to its platformization efforts and AI focused security products, has pushed the stock into the spotlight as investors reassess its recurring revenue profile. See our latest analysis for Palo Alto Networks. The upgrade comes alongside strong price momentum, with Palo Alto Networks’ share price at $358.68 and a 30 day share price return of 24.64%. Its 1 year and 5 year total...